News

WCLC 2026: Eight-year ADAURA update shows sustained overall survival benefit with adjuvant osimertinib in resected EGFR-mutated NSCLC

WCLC 2026: Zidesamtinib demonstrates 93% response rate in TKI-naive patients with advanced ROS1-positive NSCLC

WCLC 2026: Study shows first-line amivantamab plus chemotherapy achieves longest overall survival reported in advanced NSCLC with EGFR exon 20 insertions

New analysis points to low overdiagnosis in breast cancer screening

WCLC 2026: Trial supports brain MRI surveillance alone as standard of care for small-cell lung cancer

WCLC 2026: Trial shows Tam-Peli significantly improves survival in relapsed small-cell lung cancer

WCLC 2026: Trial shows risvutatug rezetecan significantly improves overall survival in relapsed small-cell lung cancer

Giant-nucleus cells are key markers for early-stage cancer, study shows

First-in-human study attacks pancreatic cancer with laser light

Why does the immune system sometimes help tumours grow?

Impact of childhood chemotherapy on healthy tissues uncovered

In vivo immune cell engineering from bench to clinical reality